Your institution may have access to this item. Find your institution then sign in to continue.
Title
People.
Abstract
The article announces several personnel changes related to biotechnology including the appointment of Adam M. Koppel as senior vice president at Biogen Idec, the election of Robert A. Ingram as board of director at Regeneron Pharmaceuticals, and the union of Raymond Schinazi at the drug development company reViral.